Observation on the results of TACE combined with lipiodol emulsion injection on hepatic carcinoma at mid and advanced stages

Objective To evaluate the therapeutic effect of TACE combined with percutaneous CALE injection on hepatic carcinoma cases at mid and advanced stages.Methods The 56 hepatic carcinoma patients after TACE treatment were randomly divided into two groups,26 patients of TACE combined with percutaneous CALE injection were the study group,30 patients of repeated TACE were the control group.After treatment,liver CT,ultrasound,AFP were conducted.The tumor shrinkage in Two groups were compared,reduction in tumor blood supply,AFP levels and followed up one year survival rate were surveyed.Results The total effective rate,the average reduced rates of AFP,the reduction rates o blood supply to tumor in study group were 76.92%,78.26%,and 92.3%,respectively,which were significantly higher than those in control group(43.33%,45.83%,and 63.33%,respectively)(P0.05).The one-year survival rate of the study group was 96.15%,and 86.67% in the control group.There were no significant statistical in two groups(P0.05).Study group patients had no serious complications.Conclusion TACE combined with percutaneous CALE injection is safe and effect for treatment of hepatic carcinoma cases at mid and advanced stages.